Ireland: Legal Landscape Struggles To Keep Pace With The Rise Of Telemedicine

Last Updated: 13 July 2016
Article by Colin Kavanagh, Orla Keane, Ciara Farrell and Olivia Mullooly
Most Read Contributor in Ireland, October 2018

Telemedicine encompasses a wide variety of services such as teleconsultation, telemonitoring and telesurgery. Telemedicine can also include remote consultation/e-visits or video conferences between health professionals and can be delivered through various forms of IT systems including mobile phone apps.

It is this complexity in delivery that causes headaches for the legal landscape due to the interplay between the regulation of healthcare services, medical devices, intellectual property and data protection when offering telemedicine services.

DEFINITION AND SCOPE OF TELEMEDICINE

The nature and scope of telemedicine can be somewhat difficult to define. At present, most European Union Member States have not adopted legal instruments specifically regulating telemedicine, including Ireland. Therefore, there is no legal definition of telemedicine in Ireland. The European Commission defines telemedicine as "the provision of healthcare services, through the use of ICT, in situations where the health professional and the patient (or two health professionals) are not in the same location. It involves secure transmission of medical data and information, through text, sound, images or other forms needed for the prevention, diagnosis, treatment and follow-up of patients".1 The Irish Health Service Executive and the Department of Health have published similar definitions.2

It is worth noting that phrases such as "telemedicine" "eHealth", "telehealth", "telecare", and "connected health" are all used interchangeably in this context. This has only added to the uncertainty surrounding the scope and nature of telemedicine services.

HEALTHCARE SERVICES

It is well established that telemedicine is a service and as such falls under the provisions of the Treaty on the Functioning of the European Union (i.e. Article 56 – freedom to provide services). This includes the freedom for citizens to receive health services from another Member State, regardless of how the service is delivered, i.e. through telemedicine.

Directive 2011/24/EU which was transposed in Ireland by the European Union (Application of Patients' Rights in Cross-Border Healthcare) Regulations 2015 endorses the right that all EU citizens are entitled to receive health services from another Member State, regardless of how the service is delivered, i.e. through telemedicine. The 2015 Regulations came into operation in Ireland on 1 June 2014.

Patients have the right to be reimbursed for the provision of cross-border health services, which includes cross-border telemedicine services. However, reimbursement will occur only if the telemedicine service falls within the range of healthcare services to which citizens are entitled in the Member State of affiliation. Ireland is the Member State of affiliation for persons insured in Ireland who are receiving medical treatment in another country.

Additionally, cross-border healthcare is to be provided in accordance with the legislation of the Member State of treatment. For the purposes of the 2015 Regulations, the provision of telemedicine is considered to have taken place in the Member State in which the healthcare provider is established.

One issue that arises in this regard is the recognition of professional qualifications. In Ireland, the Medical Practitioners Act, 2007 (as amended) requires all medical practitioners practicing in Ireland to be on the register maintained by the Medical Council of Ireland. However, according to the Directive and the 2015 Regulations, a healthcare provider providing treatment outside Ireland to patients in Ireland is considered to be providing medical treatment in the Member State in which he or she is established. As such, the medical practitioner would not need to be registered with the Medical Council, as he or she would not be providing treatment in Ireland.

MEDICAL DEVICES LEGISLATION

The provision of telemedicine services may also evoke the application of the EU medical devices legislation, namely Directive 93/42/EEC, Directive 98/79/ EEC and Directive 90/385/EEC. This is due to the fact that manufacturers of mobile health applications and devices that support telemedicine services must comply with multiple, and often conflicting, regulatory requirements promulgated by various regulatory authorities.

Qualification of a device or software as a medical device can trigger a number of related regulatory requirements. These include conducting clinical investigations on the device, undergoing a conformity assessment procedure and CE marking the device.

Software embedded or incorporated into medical hardware (e.g. software that controls a CT scanner) is deemed to be a medical device as it is an integral part of the medical device. By contrast, "standalone software" such as medical health apps will be considered a medical device only if it has a "medical purpose". Pursuant to Directive 93/42/EEC, standalone software has a "medical purpose" if it is intended by the manufacturer to be used for the purposes of:

"diagnosis, prevention, monitoring, treatment or alleviation of disease;

diagnosis, monitoring, treatment, alleviation of, or compensation for, an injury or handicap;

investigation, replacement or modification of the anatomy or of a physiological process; or

control of conception."

The information in the instructions for use, labelling and promotional materials related to the device is important when determining the manufacturer's intended purpose.

Software that monitors a patient and collects information entered by the user, measured automatically by the app or collected by a point of care device may qualify as a medical device if the output affects the treatment of an individual. On the other hand, software that provides general information but does not provide personalised advice, although it may be targeted to a particular user group, is unlikely to be considered a medical device.

Manufacturers should consult the various guidelines issued by the regulatory authorities (including the Irish Health Products Regulatory Authority and the European Commission) on the qualification and classification of standalone software to see if your software is in fact a medical device or an in vitro diagnostic device.

DATA PROTECTION

The processing of personal data, including personal health data, is governed by the Data Protection Directive 95/46/EC, which is transposed in Ireland through the Data Protection Acts 1988 and 2003. The processing of sensitive information such as health information is subject to stricter requirements than other types of personal data.

Directive 95/46/EC does not define health data. However, according to the Article 29 Working Party, which includes representatives of the national data protection authorities in the EU, health data is not only data which is inherently or clearly medical data, but also includes raw sensor data which can be used in combination with other data to draw conclusions about the health status or risk of a person, irrespective of whether these conclusions are inaccurate, illegitimate or inadequate. Thus, while an app that tracks an individual's steps during a given day may not provide significant substance with regard to a person's health, it may provide information on a health condition when analysed in combination with other relevant personal information.

The processing of health data is prohibited unless it can meet one of the permitted exemptions in Directive 95/46/EC, which includes obtaining the explicit consent of the relevant individual. There are also other requirements beyond the need to obtain consent. All personal data must be processed fairly and lawfully and collected solely for specified, explicit and legitimate purposes. Appropriate technical and organisational measures must be implemented to ensure the security and confidentiality of the data.

It should be noted that the new EU General Data Protection Regulation ("GDPR") will replace the existing Directive 95/45/EC, with a more harmonised approach to data protection across the EU. As a regulation, the GDPR will be directly applicable in the member states, without the need for any implementing legislation.

The new safeguards adopted by the regulation will include the obligation on controllers to introduce data protection by design and default into their processing systems. They will also be obliged to produce a data protection impact assessment ("DPIA") where proposed data processing is likely to result in a high risk to the rights and freedoms of individuals. It is important to note that a DPIA is not mandatory when doctors or healthcare professionals process health data concerning their patients. Additionally, the Irish Data Protection Commissioner is permitted to publish a list of processing operations that do not require a DPIA. Many organisations using health data may, therefore, need to carry out DPIAs before processing personal health data.

CONCLUSION

While telemedicine has obvious benefits such as improving patient care and healthcare system efficiency, a fragmented legal landscape which involves compliance with the various different legal regimes discussed above could hinder such benefits.

Companies offering telemedicine services must keep this in mind and take a holistic approach when navigating the relevant legal and regulatory requirements. Getting the key players involved at this early stage will also help identify any gaps in assessment. As telemedicine is a moving target, companies should also keep a dialogue with the relevant regulatory authorities to confirm whether the authorities are drafting or preparing any guidance that might be relevant.

Footnotes

1 Communication on telemedicine for the ben­efit of patients, healthcare systems and society, COM(2008)689

2 eHealth Strategy for Ireland

This article contains a general summary of developments and is not a complete or definitive statement of the law. Specific legal advice should be obtained where appropriate.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Topics
 
Related Articles
 
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions